ARTICLE | Clinical News
Cerenis HDL regulatory update
September 15, 2014 7:00 AM UTC
Cerenis said the European Commission granted Orphan Drug designation to CER-001 to treat apolipoprotein A-1 (APOA1) and ATP-binding cassette transporter 1 ( ABCA1) deficiencies. The company said inhe...